BioNTech has launched global clinical trials for BNT116, an mRNA vaccine designed to treat non-small cell lung cancer.

The Covid booster jab autumn scheme is opening in just a few days with some Brits eligible and encouraged to get their ...

The University of Dundee and NHS Tayside is the first hospital site in Europe to open a trial of a new investigational ...

A federal judge has dismissed a lawsuit by a New York family who claimed the Department of Defense misled Americans into ...

A federal judge in Washington D.C. cited the government’s “general immunity” in dismissing a lawsuit that accused the ...

The announcement comes as the administration is trying to encourage people to get the updated COVID-19 vaccines from ...

Pfizer is removing its Oxbryta pill for sickle cell disease from all markets globally due to safety risks, including deaths.

Vaccines have to meet high effectiveness and safety standards before they are offered to the public and continue to maintain a good ongoing safety record. In Aotearoa New Zealand (NZ) Medsafe has a ...

Firms faced off at two trials in London earlier this year centred on the use of messenger RNA (mRNA) technology in ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...

OncoC4 is taking AcroImmune—and its in-house clinical manufacturing capabilities—under its wing in an all-stock merger. | ...